Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease
- PMID: 15174009
- DOI: 10.1002/ana.20102
Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease
Comment on
-
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.Ann Neurol. 2003 Sep;54(3):403-14. doi: 10.1002/ana.10720. Ann Neurol. 2003. PMID: 12953276 Clinical Trial.
Similar articles
-
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease.Exp Neurol. 1997 Mar;144(1):4-9. doi: 10.1006/exnr.1996.6379. Exp Neurol. 1997. PMID: 9126143 Review.
-
Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.Neurodegener Dis. 2008;5(3-4):114-7. doi: 10.1159/000113678. Epub 2008 Mar 6. Neurodegener Dis. 2008. PMID: 18322366
-
Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.Neurosci Res. 2005 Mar;51(3):299-308. doi: 10.1016/j.neures.2004.12.006. Epub 2005 Jan 8. Neurosci Res. 2005. PMID: 15710494
-
Dopamine agonists and Parkinson's disease progression: what can we learn from neuroimaging studies.Ann Neurol. 2003;53 Suppl 3:S160-6; discussion S166-9. doi: 10.1002/ana.10486. Ann Neurol. 2003. PMID: 12666107 Review. No abstract available.
-
The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.Neurosurgery. 2007 Jan;60(1):17-28; discussion 28-30. doi: 10.1227/01.NEU.0000249209.11967.CB. Neurosurgery. 2007. PMID: 17228250 Review.
Cited by
-
Parkinson's disease brain mitochondria have impaired respirasome assembly, age-related increases in distribution of oxidative damage to mtDNA and no differences in heteroplasmic mtDNA mutation abundance.Mol Neurodegener. 2009 Sep 23;4:37. doi: 10.1186/1750-1326-4-37. Mol Neurodegener. 2009. PMID: 19775436 Free PMC article.
-
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.Exp Mol Med. 2013 Nov 15;45(11):e54. doi: 10.1038/emm.2013.94. Exp Mol Med. 2013. PMID: 24232253 Free PMC article. Review.
-
Strengths and limitations of genetic mouse models of Parkinson's disease.Parkinsonism Relat Disord. 2008;14 Suppl 2(Suppl 2):S84-7. doi: 10.1016/j.parkreldis.2008.04.004. Epub 2008 Jun 27. Parkinsonism Relat Disord. 2008. PMID: 18585084 Free PMC article. Review.
-
In vivo electrophysiology of nigral and thalamic neurons in alpha-synuclein-overexpressing mice highlights differences from toxin-based models of parkinsonism.J Neurophysiol. 2013 Dec;110(12):2792-805. doi: 10.1152/jn.00441.2013. Epub 2013 Sep 25. J Neurophysiol. 2013. PMID: 24068758 Free PMC article.
-
Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice.PLoS One. 2010 Jan 19;5(1):e8762. doi: 10.1371/journal.pone.0008762. PLoS One. 2010. PMID: 20098733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical